Cargando…
Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy
OBJECTIVE: We examined a cohort of Australian patients with statin exposure who developed a necrotizing autoimmune myopathy (NAM) associated with a novel autoantibody against 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and describe the clinical and therapeutic challenges of managing thes...
Autores principales: | Ramanathan, Sudarshini, Langguth, Daman, Hardy, Todd A., Garg, Nidhi, Bundell, Chris, Rojana-Udomsart, Arada, Dale, Russell C., Robertson, Thomas, Mammen, Andrew L., Reddel, Stephen W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386794/ https://www.ncbi.nlm.nih.gov/pubmed/25866831 http://dx.doi.org/10.1212/NXI.0000000000000096 |
Ejemplares similares
-
Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018) -
Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin
por: Allenbach, Yves, et al.
Publicado: (2014) -
Unusual Skin Involvement in Statin-induced Anti-HMGCR Immune-mediated Necrotizing Myopathy
por: SCARD, Camille, et al.
Publicado: (2021) -
Cognitive Impairment and Risk Factors in Post-COVID-19 Hospitalized Patients
por: Khieukhajee, Jedsada, et al.
Publicado: (2023) -
A Rare Case of Anti-HMGCR and Anti-SRP-Positive Immune-Mediated Necrotizing Myopathy
por: Khan, Nariman, et al.
Publicado: (2022)